Abivax (AAVXF) Treasury Shares (2022 - 2025)
Abivax (AAVXF) posted Treasury Shares of -$2.1 million for Q4 2025, down 466.19% on a QoQ basis from -$362253.8 in Q4 2024, and down 466.19% year-over-year from $560104.1 in Q4 2024.
Analysis
Abivax (AAVXF) Treasury Shares (2022 - 2025) Analysis & Trends
Abivax has reported Treasury Shares for 4 years, with the latest figure at -$2.1 million in Q4 2025.
- On a quarterly basis, Treasury Shares fell 466.19% year-over-year to -$2.1 million in Q4 2025; TTM through Dec 2025 was -$2.1 million, a 466.19% decrease from a year earlier, with the FY2025 full-year figure at -$2.1 million, down 466.19% from the prior year.
- Treasury Shares was -$2.1 million for Q4 2025 at Abivax, down from -$362253.8 in the prior quarter.
- The five-year high for Treasury Shares was $463.8 million in Q4 2024, with the low at -$36.6 million in Q4 2023.
- Average Treasury Shares over 4 years is -$1.2 million, with a median of -$1.1 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares surged 80.89% in 2024, then slumped 466.19% in 2025.
- Over 4 years, Treasury Shares stood at -$345863.9 in 2022, then sank by 448.14% to -$1.9 million in 2023, then soared by 80.89% to -$362253.8 in 2024, then plunged by 466.19% to -$2.1 million in 2025.
- The last three Treasury Shares figures came in at -$2.1 million (Q4 2025), -$362253.8 (Q4 2024), and -$1.9 million (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.37 Bn | 197.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.12 Bn | 177.94 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.11 Bn | 124.26 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn | 36.40 Mn |
| 5 | Argenx Se | 61.69 Bn | 56.50 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.62 Bn | 49.48 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.14 Bn | 30.84 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn | -23.80 Mn |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn | - |
| 10 | Abivax | 10.92 Bn | 10.92 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -2.05 Mn |
| Dec 31, 2025 | -2.05 Mn |
| Dec 31, 2024 | -362,253.84 |
| Dec 31, 2024 | 463.77 Mn |
| Dec 31, 2024 | -362,253.84 |
| Dec 31, 2024 | 463.77 Mn |
| Sep 30, 2024 | 131,786.34 |
| Sep 30, 2024 | 131,786.34 |
| Jun 30, 2024 | -41,998.62 |
| Jun 30, 2024 | -41,998.62 |
| Mar 31, 2024 | -6,518.17 |
| Mar 31, 2024 | -6,518.17 |
| Dec 31, 2023 | -1.90 Mn |
| Dec 31, 2023 | -36.58 Mn |
| Dec 31, 2023 | -1.90 Mn |
| Dec 31, 2023 | -36.58 Mn |
| Dec 31, 2022 | -345,863.86 |
| Dec 31, 2022 | -345,863.86 |